Cited by 56Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsCell Adhesion Molecules Research

Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells

Open access
Sondag, Cindy M., Combs, Colin K.·2004·Journal of Biological Chemistry

Abstract

Alzheimer's disease is a progressive neurodegenerative disorder characterized by extracellular deposition of beta-amyloid (Abeta) peptide containing neuritic plaques. Abeta peptides are proteolytically derived from the membrane-bound amyloid precursor protein (APP). Although the function of APP is not entirely clear, previous studies demonstrate that neuronal APP colocalizes with beta(1) integrin receptors at sites of focal adhesion, suggesting that APP is involved in mediating neuronal process adhesion. Integrin-dependent adhesion is also a well-characterized component of immune cell proinflammatory activation. Using primary mouse microglia and the human monocytic cell line, THP-1, we have begun investigating the role of APP in integrin-dependent activation. Co-immunoprecipitation studies demonstrate that APP is recruited into a multi-receptor signaling complex during beta(1) integrin-mediated adhesion of monocytes. Stimulation induces a subsequent, specific recruitment of tyrosine phosphorylated proteins to APP, including Lyn and Syk. Antibody cross-linking of cell surface APP leads to a similar response characterized by activation and recruitment of tyrosine kinases to APP as well as subsequent activation of mitogen-activated protein kinases and increased proinflammatory protein levels. These data demonstrate that APP can act as a proinflammatory receptor in monocytic lineage cells and provide insight into the contribution of this protein to the inflammatory conditions described in Alzheimer's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m313747200

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is evidence that alternative APP-derived fragments as well as APP itself play important roles in the modulation of immune cell activation, protein clearance, and lipid homeostasis.

    “Indeed, there is evidence that alternative APP-derived fragments as well as APP itself play important roles in the modulation of immune cell activation [160], protein clearance [161], and lipid homeostasis [162].”

    From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [160]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 41 · Cited by 56

Research works printed but not linked: 2

  1. Guenette, S. Y., Chen, J., Jondro, P. D., and Tanzi, R. E. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 10832-10837
  2. Yurochko, A. D., Liu, D. Y., Eierman, D., and Haskill, S. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9034 -9038

Authors
Sondag, C. M., & Combs, C. K.
Affiliations
University of North Dakota (US)
Corresponding author
Combs, Colin K.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2004-04
Volume
279
Issue
14
Pages
14456-14463
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2074841642
Cited by
56
References
41
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 4 · 2020: 3 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 2 · 2012: 3
FWCI
2.71
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Center for Research Resources (1P20 RR 17699-01, P20RR017699)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
Keywords
amyloid precursor protein, amyloid-beta, Alzheimer's disease, beta1 integrin, pro-inflammatory activation, microglia, THP-1 cells, Lyn kinase, Syk, tyrosine kinase signaling, MAPK activation, neuroinflammation, receptor signaling complex
MeSH terms
Animals, Cell Adhesion, Humans, Leukemia, Monocytic, Acute, Mice, Inbred C57BL, Monocytes, Amyloid beta-Protein Precursor, Microglia, Integrin beta1, Cell Lineage, Collagen Type I, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review